Medicare Enrolled
Dr. Haiyun Wang, MD
Hematology & Oncology · Danville, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wang
Dr. Haiyun Wang is a hematology & oncology specialist in Danville, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Wang performed 138,539 Medicare services across 4,395 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wang received a total of $6,119 from 21 pharmaceutical and/or device companies across 54 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 3% volume in PA
$6,119 industry payments
Medicare Practice Summary
Medicare Utilization ↗138,539
Medicare services
Top 3% in PA for hematology & oncology
4,395
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~7,697 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
27,580 | $2 | $10 |
| Nivolumab injection (Opdivo) | 16,960 | $23 | $40 |
| Pembrolizumab injection (Keytruda) | 15,402 | $39 | $67 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
10,035 | $0 | $3 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
9,830 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 9,480 | $18 | $33 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
9,150 | $0 | $1 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
7,380 | $38 | $66 |
| Paclitaxel chemotherapy injection | 4,743 | $0 | $1 |
| Iron infusion (Monoferric) | 3,900 | $17 | $36 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,565 | $0 | $0 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
2,065 | $5 | $32 |
| Injection, docetaxel, 1 mg | 2,024 | $1 | $4 |
| Injection, atropine sulfate, 0.01 mg | 1,840 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,760 | $1 | $7 |
| Bevacizumab-bvzr biosimilar injection, 10 mg An injection of bevacizumab-bvzr, a biosimilar medication, administered in a 10 mg dose. |
1,360 | $24 | $78 |
| Injection, granisetron hydrochloride, 100 mcg | 1,060 | $0 | $2 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,015 | $8 | $9 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
964 | $8 | $13 |
| Injection, fulvestrant, 25 mg | 700 | $8 | $110 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
633 | $10 | $18 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
617 | $131 | $277 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
558 | $21 | $52 |
| Pegfilgrastim-jmdb injection An injection of pegfilgrastim-jmdb, a biosimilar medication. The dose specified is 0.5 mg. |
492 | $99 | $459 |
| Injection, leucovorin calcium, per 50 mg | 490 | $3 | $13 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
459 | $95 | $242 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
440 | $2 | $10 |
| Injection, irinotecan, 20 mg | 410 | $2 | $12 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
384 | $78 | $580 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
380 | $10 | $36 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 308 | $3 | $24 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
299 | $2 | $12 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
264 | $11 | $38 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
263 | $87 | $198 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
152 | $21 | $71 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
148 | $7 | $52 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
146 | $13 | $23 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
142 | $48 | $127 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
135 | $52 | $121 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
118 | $16 | $28 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
114 | $10 | $29 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
111 | $1 | $3 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
102 | $6 | $10 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
102 | $44 | $115 |
| Iron level test | 93 | $6 | $11 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
93 | $9 | $15 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
89 | $17 | $34 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
87 | $133 | $306 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
85 | $59 | $128 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
82 | $7 | $11 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
77 | $25 | $60 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
74 | $1 | $6 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
70 | $1 | $3 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 67 | $131 | $596 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
61 | $24 | $95 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
61 | $15 | $36 |
| New patient office visit, complex (60-74 min) | 59 | $162 | $325 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
57 | $18 | $32 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
50 | $40 | $120 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
49 | $125 | $296 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
41 | $91 | $158 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
40 | $1 | $5 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
34 | $16 | $44 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
33 | $114 | $252 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
33 | $2 | $7 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
30 | $15 | $34 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
30 | $75 | $184 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
19 | $25 | $47 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 18 | $20 | $35 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
15 | $61 | $110 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
12 | $8 | $11 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.9% high complexity
92.5% medium
3.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,119
Total received (2018-2024)
Avg $1,530/year across 4 years
Top 29% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
54
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,978 (81.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$749 (12.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$393 (6.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,098
2023
$1,630
2022
$367
2018
$24
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,049
BeiGene USA, Inc.
$707
SOBI, INC
$211
Astellas Pharma US Inc
$35
Alexion Pharmaceuticals, Inc.
$26
Spectrum Pharmaceuticals Inc.
$19
GENZYME CORPORATION
$14
Eisai Inc.
$13
Fresenius Kabi USA, LLC
$13
Rigel Pharmaceuticals, Inc.
$11
Top 3 companies account for 96.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,319
AVEO Pharmaceuticals, Inc.
$1,098
BeiGene USA, Inc.
$721
Daiichi Sankyo Inc.
$255
SOBI, INC
$211
E.R. Squibb & Sons, L.L.C.
$94
EMD Serono, Inc.
$62
Astellas Pharma US Inc
$60
Rigel Pharmaceuticals, Inc.
$43
Celgene Corporation
$43
GENZYME CORPORATION
$42
Alexion Pharmaceuticals, Inc.
$26
Agios Pharmaceuticals, Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$24
Spectrum Pharmaceuticals Inc.
$19
ARRAY BIOPHARMA INC
$14
Eisai Inc.
$13
ADC Therapeutics America, Inc.
$13
Fresenius Kabi USA, LLC
$13
EUSA Pharma (US) LLC
$12
SECURA BIO, INC.
$10
Top 3 companies account for 84.0% of all-time payments
Associated products mentioned in payments ›
BRUKINSA · CABLIVI · COPIKTRA · ENHERTU · ENJAYMO · Enhertu · FOTIVDA · IMFINZI · LIBTAYO · LYNPARZA · Lenvima · OPDIVO · PYRUKYND · Pomalyst · REBLOZYL · ROLVEDON · Rezlidhia · Stimufend · Sylvant · Truqap · Turalio · ULTOMIRIS · VONJO · XALKORI · Xospata
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (81%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Hematology & oncology specialists within 10 mi
14
Per 100K population
77.4
County median income
$72,926
Nearest hospital
GEISINGER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wang is a mixed practice specialist, with above-average Medicare volume (top 3% in PA), with consulting-driven industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wang experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Wang performed 27,580 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wang receive payments from pharmaceutical companies?
Yes. Dr. Wang received a total of $6,119 from 21 companies across 54 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wang's costs compare to other hematology & oncology specialists in Danville?
Dr. Wang's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Danville
Browse hematology & oncology specialists in Danville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
AVEO Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from AVEO Pharmaceuticals, Inc.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology